αO-Conotoxin GeXIVA[1,2] Reduced Neuropathic Pain and Changed Gene Expression in Chronic Oxaliplatin-Induced Neuropathy Mice Model.
Journal Information
Full Title: Mar Drugs
Abbreviation: Mar Drugs
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"the rna sequencing raw data have been deposited in the gene expression omnibus--ncbi ( https://www ncbi nlm nih gov/geo/ ) with the accession number gse253183 (accessed on 18 january 2024)."
"Conflicts of Interest Hainan University holds a patent for GeXIVA on which S.L., D.Z. and J.M.M. are inventors."
"This work was supported in part by the Major Intergovernmental Joint Research Project of National Key R & D Program of China (SQ2022YFE010956), Guangxi Science and Technology Base & Talents Fund (GUIKE AD22035948), Major International Joint Research Project of National Natural Science Foundation of China (82320108019), National Natural Science Foundation of China Grant 82360698 & 42376112, the 111 Project (D20010), and U.S. National Institutes of Health, grant number R35 GM136430, to J.M.M."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025